Dr. Reddy's Laboratories Ltd. have received the Establishment Inspection Report (EIR) from US FDA, for the the Formulations Manufacturing facility at Shreveport, Louisiana, USA, indicating closure of the audit and the inspection classification of this facility is determined as No Action Indicated (NAI).
Shares of DR.REDDY's LABORATORIES LTD. was last trading in BSE at Rs.2819.25 as compared to the previous close of Rs. 2812.35. The total number of shares traded during the day was 15901 in over 1435 trades.
The stock hit an intraday high of Rs. 2839.95 and intraday low of 2756.1. The net turnover during the day was Rs. 44746280.